Tevogen Inc. Dilutive Securities, Effect on Basic Earnings Per Share
Tevogen Inc. (TVGN) reported Dilutive Securities, Effect on Basic Earnings Per Share of $2.50 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:DilutiveSecurities · last filed 2025-08-14
- Tevogen Inc. dilutive securities, effect on basic earnings per share for the quarter ending 2024-06-30 was -$2.55M.
- Tevogen Inc. dilutive securities, effect on basic earnings per share for the quarter ending 2024-03-31 was $5.05M.
| Period end | Dilutive Securities, Effect on Basic Earnings Per Share 3 month | Dilutive Securities, Effect on Basic Earnings Per Share 6 month |
|---|---|---|
| 2024-06-30 | -$2.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $2.50M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $5.05M 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |